invIOs GmbH, a privately held biotechnology company developing novel therapies for cancer, announced the participation at three upcoming investor conferences, the BIO CEO & Investor Conference, Sachs 15th Annual European Life Sciences CEO Forum and LSX World Congress.
February 3, 2022
· 3 min read